Source: Business Wire

Press Release: Complexa : Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016" report to their offering. Focal Segmental glomerulosclerosis is a rare disease that attacks the kidney's filtering units (glomeruli) causing serious scarring which leads to permanent kidney damage and even failure. Symptoms include proteinuria, edema, high cholesterol, high blood pressure and poor appetite. Risk factors include infection, obesity

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Francisco D. Salva's photo - President & CEO of Complexa

President & CEO

Francisco D. Salva

CEO Approval Rating

89/100

Read more